Sarah S. Rae
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sarah S. Rae has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Ahn
Department of Microbiology and Immunology, Columbia University, New York, NY, USA
1 shared publication - Brittney Winnitoy1 shared publication
- Courtney Coker
Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA
1 shared publication Elizabeth Barchi
1 shared publicationFangda Li
Department of Microbiology and Immunology, Columbia University, New York, NY, USA
1 shared publication- Jeffrey A. Russell
Department of Athletic Training, Laboratory for Science and Health in Artistic Performance, Ohio University , Athens, OH 45701
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2024 (1)
Guidelines for Returning to Dance Following Concussion: Adaptations From Sport Concussion Literature
Sport concussion receives substantial attention as a public health concern. Conversely, performing artists, including dancers, sustain concussions, but these aesthetic athletes do not receive the same level of consideration nor care for this injury as that offered to traditional athletes. The concussion literature pertaining to dance is sparse, and, to our knowledge, no recommendations exist for the crucial aspect of care related to returning to dance following a concussion. The purpose of this article is to assimilate the current knowledge about post‐concussion return to activity management in sport—the closest analog of the physical demands required in dance—as a means to delineate a framework for returning to dance following a concussion. Specific guidance is provided based on a review of evidence‐based practice so clinicians can ensure that dancers return safely to both their dance activity and any academic work they are required to undertake. Concussion in dance is not an infrequent occurrence and dancers and healthcare practitioners alike will benefit from dance‐specific guidance for returning to dance post‐concussion. Overall, the principles that form the foundation for return‐to‐sport decisions are remarkably robust for application to dance.
- 1 January 2024
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2024 (1)
Open AccessGuidelines for Returning to Dance Following Concussion: Adaptations From Sport Concussion Literature
Sport concussion receives substantial attention as a public health concern. Conversely, performing artists, including dancers, sustain concussions, but these aesthetic athletes do not receive the same level of consideration nor care for this injury as that offered to traditional athletes. The concussion literature pertaining to dance is sparse, and, to our knowledge, no recommendations exist for the crucial aspect of care related to returning to dance following a concussion. The purpose of this article is to assimilate the current knowledge about post‐concussion return to activity management in sport—the closest analog of the physical demands required in dance—as a means to delineate a framework for returning to dance following a concussion. Specific guidance is provided based on a review of evidence‐based practice so clinicians can ensure that dancers return safely to both their dance activity and any academic work they are required to undertake. Concussion in dance is not an infrequent occurrence and dancers and healthcare practitioners alike will benefit from dance‐specific guidance for returning to dance post‐concussion. Overall, the principles that form the foundation for return‐to‐sport decisions are remarkably robust for application to dance.
- Top Cited Papers
- 10 March 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (10) , eadc9436
Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity
Tumors use multiple mechanisms to actively exclude immune cells involved in antitumor immunity. Strategies to overcome these exclusion signals remain limited due to an inability to target therapeutics specifically to the tumor. Synthetic biology enables engineering of cells and microbes for tumor-localized delivery of therapeutic candidates previously unavailable using conventional systemic administration techniques. Here, we engineer bacteria to intratumorally release chemokines to attract adaptive immune cells into the tumor environment. Bacteria expressing an activating mutant of the human chemokine CXCL16 (hCXCL16 K42A ) offer therapeutic benefit in multiple mouse tumor models, an effect mediated via recruitment of CD8 + T cells. Furthermore, we target the presentation of tumor-derived antigens by dendritic cells, using a second engineered bacterial strain expressing CCL20. This led to type 1 conventional dendritic cell recruitment and synergized with hCXCL16 K42A -induced T cell recruitment to provide additional therapeutic benefit. In summary, we engineer bacteria to recruit and activate innate and adaptive antitumor immune responses, offering a new cancer immunotherapy strategy.
- 10 March 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (10) , eadc9436
Top Cited PapersChemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity
Tumors use multiple mechanisms to actively exclude immune cells involved in antitumor immunity. Strategies to overcome these exclusion signals remain limited due to an inability to target therapeutics specifically to the tumor. Synthetic biology enables engineering of cells and microbes for tumor-localized delivery of therapeutic candidates previously unavailable using conventional systemic administration techniques. Here, we engineer bacteria to intratumorally release chemokines to attract adaptive immune cells into the tumor environment. Bacteria expressing an activating mutant of the human chemokine CXCL16 (hCXCL16 K42A ) offer therapeutic benefit in multiple mouse tumor models, an effect mediated via recruitment of CD8 + T cells. Furthermore, we target the presentation of tumor-derived antigens by dendritic cells, using a second engineered bacterial strain expressing CCL20. This led to type 1 conventional dendritic cell recruitment and synergized with hCXCL16 K42A -induced T cell recruitment to provide additional therapeutic benefit. In summary, we engineer bacteria to recruit and activate innate and adaptive antitumor immune responses, offering a new cancer immunotherapy strategy.